Collagenase production is lower in post-burn hypertrophic scar fibroblasts than in normal fibroblasts and is reduced by insulin-like growth factor-1

Journal of Investigative Dermatology

Volumn 106, Issue 3, 1996, Pages 476-481

  Ghahary, Aziz ^a   Shen, You J ^a   Nedelec, Bernadette ^a   Wang, Rijian ^a   Scott, Paul G ^a   Tredget, Edward E ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

TIMP 1

Indexed keywords

COLLAGEN TYPE 1; COLLAGENASE; MESSENGER RNA; SOMATOMEDIN C;

ADOLESCENT; ADULT; ARTICLE; BURN; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; FIBROBLAST; HUMAN; HUMAN TISSUE; HYPERTROPHIC SCAR; PRIORITY JOURNAL;

EID: 0029869972     PISSN: 0022202X     EISSN: None     Source Type: Journal    
DOI: 10.1111/1523-1747.ep12343658     Document Type: Article

References (26)

1. Abergel RP, Pizzurro D, Meek CA, Lask G, Matsuoka LY, Minor RR, Chu ML, Uitto J: Biochemical composition of the connective tissue in keloids and analysis of collagen metabolism in keloid fibroblast cultures. J Invest Dermatol 84:384-390, 1985
2. Ala-Kokko L, Rintala A, Savolainen ER: Collagen gene expression in keloid: analysis of collagen metabolism and type I, III, IV and V procollagen mRNAs in keloid tissue and keloid fibroblast cultures. J Invest Dermatol 89:238-244, 1987
3. Chirgwin JM, Pryzbyla AE, MacDonald RJ, Rutter WJ: Isolation of biologically active ribonucleic acid from sources enriched in ribonucleases. Biochemistry 18:5294-5299, 1979
4. Cohen IK, Keiser HR, Sjoerdsma A: Collagen synthesis in human keloid and hypertrophic scar. Surg Forum 22:488-489, 1971
5. Edwards DR, Murphy G, Reynolds JJ, Whitam SE, Docherty AJP, Angel P, Heath JK: Transforming growth factor-beta stimulates the expression of collagenase and metalloproteinase inhibitor. EMBO J 6:1899-1904, 1987
6. Ghahary A, Scott PG, Malhotra S, Friedland UA, Harrop R, Forsyth NL, Tredget EE: Differential expression of type I and type III procollagen mRNA in human hypertrophic burn firoblasts. Biomed Lett 47:169-184, 1992
7. Ghahary A, Shen YJ, Gong Y, Scott PG, Tredget EE: Enhanced expression of mRNA for transforming growth factor β1, type 1, type III procollagen in human post-burn hypertrophic scar tissues. J Lab Clin Med 122:465-473, 1993
8. Ghahary A, Shen YJ, Nedelec B, Scott PG, Tredget EE: Enhanced expression of mRNA for insulin-like growth factor-1 in post burn hypertrophic scar tissue and its fibrogenic role by dermal fibroblasts. Mol Cell Biochem 148:25-32, 1995a
9. Ghahary A, Shen YJ, Nedelec B, Scott PG, Tredget EE: Interferon gamma and alpha-2b differentially regulate the expression of collagenase and TIMP-1 mRNA in human hypertrophic and normal dermal fibroblasts. Wound Rep Reg 3:13-21, 1995b
10. Ghahary A, Shen YJ, Scott PG, Tredget EE: Immunolocalization of TGF-β1 in human hypertrophic scar and normal dermal tissues. Cytokine 7:184-190, 1995c
11. Ignotz RA, Massague J: Transforming growth factor-β stimulates the expression of fibronectin and collagen and their incorporation into the extracellular matrix. J Biol Chem 261:4337-4345, 1986
12. Jeffrey JJ: Collagen degradation. In: Cohen IK, Diegelmann RF, Lindblad WJ (eds.). Wound Healing, W.B. Saunders, Philadelphia, 1992, pp 177-194
13. Mann JS, Kidney MS, Edwards DR, Curry TE: Hormonal regulation of matrix metalloproteinase inhibitor in rat granulosa cells and ovaries. Endocrinology 128:1825-1832, 1991
14. McCarthy TL, Centrella M, Canalis E: Regulatory effect of insulin-like growth factor I and II on bone collagen synthesis in rat calvarial cultures. Endocrinology 124:301-309, 1989
15. McCoy BJ, Cohen IK: Collagenase in keloid biopsies and fibroblasts. Connect Tissue Res 9:181-185, 1982
16. Murphy LJ, Ghahary A: Uterine insulin-like growth factor-1: Regulation of expression and its role in estrogen-induced uterine proliferation. Endocr Rev 11:443-453, 1990
17. Mustoe TA, Pierce GF, Thomason A, Gramates P, Sporn MB, Deuel TF: Transforming growth factor type beta induces accelerated healing of incisional wounds in rats. Science 237:1333-1336, 1987
18. Postlethwaite AE, Raghow R, Stricklin GP, Poppleton H, Seyer JM, Kang AH: Modulation of fibroblast functions by interleukin: increased steady-state accumulation of type 1 procollagen messenger RNAs and stimulation of other functions but not chemotaxis by human recombinant interleukin 1α and 1β. J Cell Biol 106:311-318, 1988
19. Roberts AB, Sporn MB, Assoian RK, Smith JM, Rocha NC, Wakefield LM, Heine UI, Liotta LA, Falanga V, Kehri JH, Fauci AS: Transforming growth factor type-beta: rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formations in vitro. Proc Natl Acad Sci U S A 83:4167-4171, 1986
20. Salmon WD, Daughaday WH: A hormonally controlled serum factor which stimulates sulfate incorporation by cartilage in vitro. J Lab Clin Med 49:825-836, 1957
21. Scott PG, Ghahary A, Chambers M, and Tredget EE: Biological basis of hypertrophic scarring. In: Malhotra SK (ed.). Advances in Structural Biology. Vol. 3. JAI Press, Greenwich, CT, 1994, pp 157-201
22. Spencer EM, Skover G, Hunt TK: Somatomedins: do they play a pivotal role in wound healing? In: Hunt TK, Pines E, Barbul A, Caldwell M (eds.). Growth Factors and Other Agents of Wound Healing: Biological and Clinical Implications. Alan R. Liss, New York, 1988, pp 103-116
23. Svoboda ME, Van Wyk JJ, Klapper DG, Fellows RE, Grissom FE, Schlueter RJ: Purification of somatomedin-C from human plasma: Chemical and biological properties, partial sequence analysis, and relationship to other somatomedins. Biochemistry 19:790-797, 1980
24. Takeda K, Hatamochi A, Ueki H, Nakata M, Oishi Y: Decreased collagenase expression in cultured systemic sclerosis fibroblasts. J Invest Dermatol 103:359-363, 1994
25. Tredget EE, Shen Y, Forsyth N, Smith C, Scott PG, Ghahary A: The effect of interferon alpha-2b on hypertrophic scar fibroblasts in vitro. Wound Rep Reg 1:156-165, 1993
26. Varga J, Olsen A, Herhal J, Constantine G, Rosenbloom J, Jimenez SA: Interferon-gamma reverses the stimulation of collagen but not fibronectin gene expression by transforming growth factor-β in normal human fibroblasts. Eur J Clin Invest 20:487-493, 1986